← Back to all trials
Active Not Recruiting
NCT07421739
Choroidal Melanoma Patient-Reported Outcome Study (CM-PRO) in a Subset of AU-011-301 (CoMpass) Subjects
Conditions: Choroidal Melanoma, Indeterminate Lesions, Uveal Melanoma, Ocular Melanoma
Sex: All
Healthy volunteers: No
Enrollment: 15
Sponsor: Aura Biosciences
Location: Eye Research Australia East Melbourne Victoria
Summary
To assess subject-centric evidence of QoL outcomes in a subset of subjects enrolled in the global Phase 3 AU-011-301 clinical trial.
Eligibility Criteria
Inclusion Criteria:
* Have enrolled in the Aura-sponsored clinical trial AU-011-301.
Exclusion Criteria:
* None
Source: ClinicalTrials.gov (NCT07421739). StuddyBuddy aggregates publicly available trial information.
